At the frog neuromuscular junction prostaglandin synthase inhibitors depress and PGE partially restores quantal acetylcholine release.
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology; D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors; D015232:Dinoprostone; D004305:Dose-Response Relationship, Drug; D005071:Evoked Potentials / Q000187:drug effects; D007213:Indomethacin / Q000494:pharmacology; D009045:Motor Endplate / Q000187:drug effects / Q000201:enzymology; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000201:enzymology; D011458:Prostaglandins E / Q000494:pharmacology*; D011894:Rana pipiens; D012584:Sciatic Nerve / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects
D016861:Cyclooxygenase Inhibitors; D011458:Prostaglandins E; D015117:5,8,11,14-Eicosatetraynoic Acid; D015232:Dinoprostone; D000109:Acetylcholine; D002118:Calcium; D007213:Indomethacin